FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Tizanidine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 14 USDMF, 2 CEP/COS, 6 JDMF, 5 EU WC, 3 KDMF, 9 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

137 FDF Dossiers, 76 FDA Orange Book, 31 Europe, 2 Canada, 28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 SPI Pharma, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 38 Fillers, Diluents & Binders, 28 Direct Compression, 25 Granulation, 17 Disintegrants & Superdisintegrants, 17 Controlled & Modified Release, 16 Thickeners and Stabilizers, 13 Taste Masking, 10 Co-Processed Excipients, 10 Film Formers & Plasticizers, 9 Empty Capsules, 9 Lubricants & Glidants, 8 Chewable & Orodispersible Aids, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Solubilizers, 4 Emulsifying Agents, 3 Rheology Modifiers, 3 Parenteral, 2 Coloring Agents, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

12 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/02/2026	Symed Labs	India	SYMED LABS LIMITED Hyderabad IN	R0-CEP 2022-256 - Rev 00	Tizanidine hydrochloride	2023-01-05	Valid	Chemical		2578
27/02/2026	Unichem Laboratories Limited	India	UNICHEM LABORATORIES LIMITED Mumbai IN	CEP 2024-473 - Rev 00	Tizanidine hydrochloride	2026-02-11	Valid	Chemical		2578

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Tizanidine Hydrochloride

Tizanidine Hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers

14 USDMF

2 CEP/COS

6 JDMF

5 EU WC

3 KDMF

9 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

137 FDF Dossiers

76 FDA Orange Book

31 Europe

2 Canada

28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 4MG BASE

CAPSULE;ORAL - EQ 2MG BASE

CAPSULE;ORAL - EQ 4MG BASE

CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik

4 SPI Pharma

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

2 Kirsch Pharma

4 ACG Worldwide

1 Actylis

1 Aeon Procare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

10 Corel Pharma Chem

6 DFE Pharma

3 Doshion Polyscience

1 Finar

6 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

8 Microlex e.U

1 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

18 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives

38 Fillers, Diluents & Binders

28 Direct Compression

25 Granulation

17 Disintegrants & Superdisintegrants

17 Controlled & Modified Release

16 Thickeners and Stabilizers

13 Taste Masking

10 Co-Processed Excipients

TABLET;ORAL - EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons